
Brian A. Mccaig
Examiner (ID: 12226, Phone: (571)270-5548 , Office: P/1772 )
| Most Active Art Unit | 1772 |
| Art Unit(s) | 1772, 1774, 1797 |
| Total Applications | 1729 |
| Issued Applications | 1395 |
| Pending Applications | 82 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15895133
[patent_doc_number] => 20200147085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF PSYCHIATRIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/518886
[patent_app_country] => US
[patent_app_date] => 2019-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16518886
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/518886 | COMPOSITIONS AND METHODS FOR TREATMENT OF PSYCHIATRIC DISORDERS | Jul 21, 2019 | Abandoned |
Array
(
[id] => 17095260
[patent_doc_number] => 20210283051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => VE-PTP INHIBITION IN GLAUCOMA
[patent_app_type] => utility
[patent_app_number] => 17/260073
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260073
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/260073 | VE-PTP INHIBITION IN GLAUCOMA | Jul 11, 2019 | Abandoned |
Array
(
[id] => 17168658
[patent_doc_number] => 20210322328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => NANOSTRUCTURE LIPID SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/259110
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259110 | Nanostructure lipid system | Jul 9, 2019 | Issued |
Array
(
[id] => 15035451
[patent_doc_number] => 20190328730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => PREVENTING OR TREATING AGENT FOR GLAUCOMA
[patent_app_type] => utility
[patent_app_number] => 16/505010
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/505010 | PREVENTING OR TREATING AGENT FOR GLAUCOMA | Jul 7, 2019 | Abandoned |
Array
(
[id] => 15290413
[patent_doc_number] => 20190388342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => Monovalent Metal Cation Dry Powders
[patent_app_type] => utility
[patent_app_number] => 16/456990
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16456990
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/456990 | Monovalent Metal Cation Dry Powders | Jun 27, 2019 | Abandoned |
Array
(
[id] => 17065685
[patent_doc_number] => 20210267900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => PROCESSING METHOD FOR DRUG SUBSTANCE PARTICLES OF NON-UNIFORM PARTICLE SIZE
[patent_app_type] => utility
[patent_app_number] => 17/255200
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255200 | PROCESSING METHOD FOR DRUG SUBSTANCE PARTICLES OF NON-UNIFORM PARTICLE SIZE | Jun 24, 2019 | Abandoned |
Array
(
[id] => 15341075
[patent_doc_number] => 20200008429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => ALKALI METAL SALT FOR USE IN TREATMENT OF VARROA DESTRUCTOR MITE INFESTATION OF HONEY BEES
[patent_app_type] => utility
[patent_app_number] => 16/451488
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16451488
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/451488 | Alkali metal salt for use in treatment of varroa destructor mite infestation of honey bees | Jun 24, 2019 | Issued |
Array
(
[id] => 16778099
[patent_doc_number] => 20210115177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => AMPHIPHILIC POLYMERS, PROCESS OF PREPARING SAME AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/251802
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251802 | AMPHIPHILIC POLYMERS, PROCESS OF PREPARING SAME AND USES THEREOF | Jun 12, 2019 | Pending |
| 16/439706 | METHOD TO MODULATE THE SURFACE TENSION OF CANNABIS PLANT MATTER NANOPARTICULATES | Jun 12, 2019 | Abandoned |
Array
(
[id] => 17050515
[patent_doc_number] => 20210259949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => USE OF A BIXA ORELLANA EXTRACT
[patent_app_type] => utility
[patent_app_number] => 17/251247
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251247
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251247 | USE OF A BIXA ORELLANA EXTRACT | Jun 5, 2019 | Abandoned |
Array
(
[id] => 18642356
[patent_doc_number] => 11766409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Core-shell polymer nanoparticle
[patent_app_type] => utility
[patent_app_number] => 17/059770
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 9753
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059770
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059770 | Core-shell polymer nanoparticle | May 30, 2019 | Issued |
Array
(
[id] => 17539854
[patent_doc_number] => 11304958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Multidentate phenanthridine-containing ligand frameworks and their planar monofunctional platinum complexes for cancer treatment
[patent_app_type] => utility
[patent_app_number] => 17/041592
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 10916
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041592 | Multidentate phenanthridine-containing ligand frameworks and their planar monofunctional platinum complexes for cancer treatment | May 23, 2019 | Issued |
Array
(
[id] => 17874399
[patent_doc_number] => 11446392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Biomimetic vesicles and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/057415
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 42
[patent_no_of_words] => 20672
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057415 | Biomimetic vesicles and uses thereof | May 22, 2019 | Issued |
Array
(
[id] => 14833211
[patent_doc_number] => 20190275006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => SELF-EMULSIFYING PHARMACEUTICAL COMPOSITIONS OF HYDROPHILIC DRUGS AND PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/420581
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16420581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/420581 | SELF-EMULSIFYING PHARMACEUTICAL COMPOSITIONS OF HYDROPHILIC DRUGS AND PREPARATION THEREOF | May 22, 2019 | Pending |
Array
(
[id] => 17020931
[patent_doc_number] => 20210244802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => Endolysins Active Against Bacillus Bacteria, Pharmaceutical Compositions, and Methods Relating Thereto
[patent_app_type] => utility
[patent_app_number] => 17/054539
[patent_app_country] => US
[patent_app_date] => 2019-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054539
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054539 | Endolysins active against | May 15, 2019 | Issued |
Array
(
[id] => 17921517
[patent_doc_number] => 11464738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Ionic liquid-based nanoemulsion formulation for the efficient delivery of hydrophilic and hydrophobic therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 17/040916
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 90
[patent_figures_cnt] => 115
[patent_no_of_words] => 37112
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040916 | Ionic liquid-based nanoemulsion formulation for the efficient delivery of hydrophilic and hydrophobic therapeutic agents | May 9, 2019 | Issued |
Array
(
[id] => 16792939
[patent_doc_number] => 20210122756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/981745
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/981745 | Long-acting injectable formulations and crystalline forms of buprenorphine derivatives | May 9, 2019 | Issued |
Array
(
[id] => 16898816
[patent_doc_number] => 20210177732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => COMBINATION OF EXTRACTS OF QUINQUINA AND OF LEONTOPODIUM ALPINUM AND OF THE MANGANESE SALT OF L-PYRROLIDONE CARBOXYLIC ACID IN THE TREATMENT OF ALOPECIA
[patent_app_type] => utility
[patent_app_number] => 17/052694
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052694 | COMBINATION OF EXTRACTS OF QUINQUINA AND OF LEONTOPODIUM ALPINUM AND OF THE MANGANESE SALT OF L-PYRROLIDONE CARBOXYLIC ACID IN THE TREATMENT OF ALOPECIA | May 2, 2019 | Abandoned |
Array
(
[id] => 16420455
[patent_doc_number] => 20200345653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => Transdermal Composition
[patent_app_type] => utility
[patent_app_number] => 16/402128
[patent_app_country] => US
[patent_app_date] => 2019-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16402128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/402128 | Transdermal Composition | May 1, 2019 | Abandoned |
Array
(
[id] => 14991201
[patent_doc_number] => 20190314558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Anti-Adhesive Barrier Membrane Using Alginate and Hyaluronic Acid for Biomedical Applications
[patent_app_type] => utility
[patent_app_number] => 16/400259
[patent_app_country] => US
[patent_app_date] => 2019-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16400259
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/400259 | Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications | Apr 30, 2019 | Issued |